Source:http://linkedlifedata.com/resource/pubmed/id/10744681
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2000-5-8
|
pubmed:abstractText |
Lysosomal beta-D-galactosidase (beta-gal), the enzyme deficient in the autosomal recessive disorders G(M1) gangliosidosis and Morquio B, is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66-kDa mature form. The released approximately 20-kDa proteolytic fragment was thought to be degraded. We now present evidence that it remains associated to the 64-kDa chain after partial proteolysis of the precursor. This polypeptide was found to copurify with beta-gal and protective protein/cathepsin A from mouse liver and Madin-Darby bovine kidney cells and was immunoprecipitated from human fibroblasts but not from fibroblasts of a G(M1) gangliosidosis and a galactosialidosis patient. Uptake of wild-type protective protein/cathepsin A by galactosialidosis fibroblasts resulted in a significant increase of mature and active beta-gal and its C-terminal fragment. Expression in COS-1 cells of mutant cDNAs encoding either the N-terminal or the C-terminal domain of beta-gal resulted in the synthesis of correctly sized polypeptides without catalytic activity. Only when co-expressed, the two subunits associate and become catalytically active. Our results suggest that the C terminus of beta-gal is an essential domain of the catalytically active enzyme and provide evidence that lysosomal beta-galactosidase is a two-subunit molecule. These data may give new significance to mutations in G(M1) gangliosidosis patients found in the C-terminal part of the molecule.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
275
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10035-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10744681-Animals,
pubmed-meshheading:10744681-Cattle,
pubmed-meshheading:10744681-Cell Line,
pubmed-meshheading:10744681-Cells, Cultured,
pubmed-meshheading:10744681-Gangliosidosis, GM1,
pubmed-meshheading:10744681-Humans,
pubmed-meshheading:10744681-Kidney,
pubmed-meshheading:10744681-Liver,
pubmed-meshheading:10744681-Lysosomes,
pubmed-meshheading:10744681-Macromolecular Substances,
pubmed-meshheading:10744681-Mice,
pubmed-meshheading:10744681-Multienzyme Complexes,
pubmed-meshheading:10744681-Mutagenesis,
pubmed-meshheading:10744681-Recombinant Proteins,
pubmed-meshheading:10744681-Sequence Deletion,
pubmed-meshheading:10744681-Skin,
pubmed-meshheading:10744681-beta-Galactosidase
|
pubmed:year |
2000
|
pubmed:articleTitle |
Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.
|
pubmed:affiliation |
Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|